Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Leo symbols : NVS save search
Global Psoriasis Therapeutics Market Report to 2031 - Featuring Abbvie, Amgen, Bausch Health, LEO Pharma and Novan Among Others
Published: 2023-01-25 (Crawled : 21:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -1.1%
H: 0.0%
C: 0.0%
VTRS A | $11.25 1.17% 1.16% 4.7M
|
Health Technology
|
| O: -0.69%
H: 0.87%
C: 0.69%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -1.97%
H: 0.11%
C: -1.25%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.36%
H: 0.34%
C: -0.85%
BHC | $8.69 1.05% 0.0% 2.9M
|
Health Technology
|
| O: 1.91%
H: 3.28%
C: -0.23%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.09%
H: 0.53%
C: -0.35%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: 0.0%
H: 0.06%
C: -0.65%
leo pharma global report therapeutics psoriasis market
Global Naloxone (Parenteral, Intranasal, & Sublingual) Market Report 2021: Key Players are Hospira, Mylan, Kaleo, Amphastar Pharmaceuticals, Adapt Pharma, Mundipharma International - Forecast to 2029
Published: 2021-05-14 (Crawled : 15:00) - prnewswire.com
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.35%
H: 0.2%
C: -0.55%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.81%
H: 0.17%
C: -0.18%
AMPH | $39.98 3.44% 3.33% 410K
|
Health Technology
|
| O: 0.1%
H: 2.15%
C: 1.99%
leo
Attralus Therapeutics Appoints Mark Timney as CEO and Expands Leadership Team with New Executives
Published: 2021-05-10 (Crawled : 12:00) - biospace.com/
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.05%
H: 0.37%
C: -0.02%
NKTR | News | $1.265 -4.17% -4.35% 4.7M
|
Health Technology
|
| O: 0.35%
H: 0.4%
C: -2.18%
ceo leo
Novartis CEO Says Remote Work Hybrid Should Mean Access to New Talent Pools
Published: 2021-04-28 (Crawled : 17:00) - biospace.com/
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -0.37%
H: 0.7%
C: 0.58%
ceo leo
Valeo Pharma Inc. Enters into an Agreement for Enerzair® Breezhaler® and Atectura® Breezhaler® in Canada
Published: 2021-03-29 (Crawled : 15:00) - prnewswire.com
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -0.1%
H: 0.57%
C: 0.03%
leo pharma
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.